Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Clarity is a clinical stage company developing products to address the growing need for the use of radiopharmaceuticals in oncology.

Radiopharmaceuticals: Prostate cancer diagnostic revenues currently in focus, but the opportunity in therapeutics could be larger - Charlie Williams

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

Copper radiopharmaceuticals for theranostic applications - ScienceDirect

Clarity Pharmaceuticals on LinkedIn: First participant treated in the highest dose cohort of neuroblastoma…

Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Radiopharmaceuticals and Tracers

News - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Diagnostics

Technology - High Accuracy, High Precision Diagnostics and Therapy - Clarity

Clarity Pharmaceuticals Announces the US FDA Grants Rare Paediatric Disease Designation to 64Cu-SARTATE™, a diagnostic for the clinical management of neuroblastoma - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging

BOP preliminary trial results presented at EANM 2023 conference - Clarity Pharmaceuticals - Radiopharmaceutical Therapies and Imaging